Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.

Seminars in nephrology - 1 Mar 2004

Parving Hans-Henrik, Andersen Steen, Jacobsen Peter, Christensen Per K, Rossing Kasper, Hovind Peter, Rossing Peter, Tarnow Lise

Abstract excerpt

The activity of the renin-angiotensin-aldosterone system (RAAS) is elevated both in the circulation and in the renal tissue of diabetic and nondiabetic nephropathies. The increased RAAS activity plays an important role in the hemodynamic and nonhemodynamic pathogenetic mechanisms involved in kidney disease. Previous studies have demonstrated that albuminuria is not only a marker of glomerular lesions, but also a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin Receptor Antagonists
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetic Nephropathies

Share to Genotype

Share to Kidney Failure, Chronic

Share to Peptidyl-Dipeptidase A

Share to Renin-Angiotensin System

Share to Time Factors

Source

Identifiers

PMID: 15017527
DOI: 10.1016/j.semnephrol.2003.11.003

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.PMID 15017527Read ↗

Diabetic nephropathy.Semantic proximity Read ↗

Renin^|^ndash;Angiotensin System, Hypertension, and Chronic Kidney Disease: Pharmacogenetic ImplicationsSemantic proximity Read ↗

Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.Semantic proximity Read ↗

Chronic Kidney Disease in the Elderly Patient with DiabetesSemantic proximity Read ↗

Blood pressure in diabetic nephropathy--current controversies.Semantic proximity Read ↗

Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?Semantic proximity Read ↗

Treatment of cardiovascular and renal risk factors in the diabetic hypertensive.Semantic proximity Read ↗

The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: Protocol for a Systematic Review.Semantic proximity Read ↗

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.Semantic proximity Read ↗

Evaluating the Efficacy of Finerenone in Reducing Proteinuria in Diabetic Nephropathy Patients Receiving Maximum Tolerable Doses of Dapagliflozin and TelmisartanSemantic proximity Read ↗

The kallikrein-kinin system in diabetic nephropathy.Semantic proximity Read ↗

Relationship between beta1-adrenergic receptor polymorphisms and cardiovascular disease in patients with diabetic nephropathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.